高b值扩散加权与平扫T1加权图像融合诊断浸润性乳腺癌:假阴性结果相关因素
回顾性分析2018至2019年316例浸润性乳腺癌患者的术前乳腺MRI,采用高b值DWI与平扫T1WI融合图像诊断,融合DWI诊断真阳性289例(91.5%)、假阴性27例(8.5%)。多因素分析显示肿瘤≤1 cm、肿瘤内钙化及中/明显背景扩散信号与假阴性结果显著相关。
要点
- 融合高b值DWI与平扫T1WI诊断浸润性乳腺癌的假阴性率为8.5%(27/316)。
- 肿瘤≤1 cm、肿瘤内钙化及中/明显背景扩散信号是与假阴性独立相关的因素。
- 筛查发现的141例中,明显背景扩散信号仍与假阴性显著相关(OR 7.94)。
关键影像表现/征象
- 融合DWI诊断浸润性乳腺癌的真阳性为289例(91.5%),假阴性为27例(8.5%)。
- 肿瘤大小≤1 cm与假阴性结果显著相关(OR 5.95;95%CI 2.11, 16.81;p=0.001)。
- 肿瘤内存在钙化与假阴性结果显著相关(OR 3.41;95%CI 1.27, 9.15;p=0.015)。
- 中等背景扩散信号与假阴性结果显著相关(OR 4.23;95%CI 1.31, 13.67;p=0.016)。
- 明显背景扩散信号与假阴性结果显著相关(OR 19.18;95%CI 6.51, 56.46;p<0.001)。
诊断标准与关键数值
- 融合高b值DWI与平扫T1WI诊断浸润性乳腺癌的假阴性率为8.5%(27/316)。
- 肿瘤≤1 cm的假阴性OR为5.95(95%CI 2.11, 16.81;p=0.001)。
- 肿瘤内钙化的假阴性OR为3.41(95%CI 1.27, 9.15;p=0.015)。
- 中等背景扩散信号的假阴性OR为4.23(95%CI 1.31, 13.67;p=0.016),明显背景扩散信号的假阴性OR为19.18(95%CI 6.51, 56.46;p<0.001)。
- 筛查发现的141例中,明显背景扩散信号的假阴性OR为7.94(95%CI 2.30, 27.35;p=0.001)。
临床应用与阅片要点
- 采用融合高b值DWI与平扫T1WI诊断浸润性乳腺癌时,对≤1 cm肿瘤、肿瘤内钙化及中/明显背景扩散信号需警惕假阴性可能。
- 筛查发现的乳腺癌中,明显背景扩散信号仍与假阴性显著相关(OR 7.94;95%CI 2.30, 27.35;p=0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: We sought factors associated with false-negative results in the diagnosis of invasive breast cancer via non-contrast breast magnetic resonance imaging (MRI) using fused high b-value diffusion-weighted imaging (DWI) and unenhanced T1-weighted images (T1WI).
METHODS: Between 2018 and 2019, 316 consecutive women (mean age, 54.6 years) with invasive breast cancer who underwent preoperative breast MRI, including fused high b-value DWI and unenhanced T1WI, were retrospectively evaluated. Malignancy confidence ratings of the most suspicious breast lesions evident on fused DWI were derived by two radiologists using a 6-point Likert-type scale. Both clinicopathological and imaging features were analyzed. Multivariate regression analysis was performed to identify factors associated with false-negative DWI results in the diagnosis of invasive breast cancer.
RESULTS: Of the 316 breast cancers, fused DWI yielded 289 (91.5%) true-positive and 27 (8.5%) false-negative results. Multivariate analysis showed that small tumor size (≤ 1 cm) (odds ratio [OR], 5.95; 95% confidence interval [CI], 2.11, 16.81; p = 0.001), presence of calcifications in the tumor (OR, 3.41; 95% CI, 1.27, 9.15; p = 0.015), and a moderate/marked background diffusion signal (ORs, 4.23 and 19.18; 95% CI, 1.31, 13.67 and 6.51, 56.46; p = 0.016 and p < 0.001, respectively) were significantly associated with false-negative results. In subgroup analysis of 141 screening-detected cancers, a marked background diffusion signal (OR, 7.94; 95% CI, 2.30, 27.35; p = 0.001) remained significantly associated with false-negative results in the multivariate analysis.
CONCLUSIONS: In addition to histopathological features, a higher background diffusion signal was associated with false-negative results in the diagnosis of invasive breast cancer via non-contrast MRI using fused high b-value DWI and unenhanced T1WI.
KEY POINTS: • Subcentimeter tumors and presence of calcifications in the tumor are associated with false-negative diffusion-weighted imaging results in the diagnosis of invasive breast cancer. • A higher degree of background diffusion signal may lead to false-negative interpretation of diffusion-weighted imaging in patients with invasive breast cancer.
引用
- Kim JJ, Kim JY. Fusion of high b-value diffusion-weighted and unenhanced T1-weighted images to diagnose invasive breast cancer: factors associated with false-negative results. Eur Radiol. 2021. PMID: 33443601. doi:10.1007/s00330-020-07644-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。